CN113825837A - 利用环形rna进行蛋白翻译及其应用 - Google Patents
利用环形rna进行蛋白翻译及其应用 Download PDFInfo
- Publication number
- CN113825837A CN113825837A CN202080036818.2A CN202080036818A CN113825837A CN 113825837 A CN113825837 A CN 113825837A CN 202080036818 A CN202080036818 A CN 202080036818A CN 113825837 A CN113825837 A CN 113825837A
- Authority
- CN
- China
- Prior art keywords
- equal
- translation initiation
- construct
- protein
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091028075 Circular RNA Proteins 0.000 title claims abstract description 31
- 230000014616 translation Effects 0.000 title claims description 40
- 230000014621 translational initiation Effects 0.000 claims abstract description 58
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 43
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 43
- 210000004027 cell Anatomy 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 23
- 238000000338 in vitro Methods 0.000 claims description 15
- 108091026890 Coding region Proteins 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 238000001243 protein synthesis Methods 0.000 claims description 9
- 239000013598 vector Substances 0.000 claims description 9
- 108010044843 Peptide Initiation Factors Proteins 0.000 claims description 7
- 102000005877 Peptide Initiation Factors Human genes 0.000 claims description 7
- 102100039737 Eukaryotic translation initiation factor 4 gamma 2 Human genes 0.000 claims description 6
- 102100029602 Eukaryotic translation initiation factor 4B Human genes 0.000 claims description 6
- 101000959666 Homo sapiens Eukaryotic initiation factor 4A-I Proteins 0.000 claims description 6
- 101001034811 Homo sapiens Eukaryotic translation initiation factor 4 gamma 2 Proteins 0.000 claims description 6
- 101000840282 Homo sapiens Eukaryotic translation initiation factor 4B Proteins 0.000 claims description 6
- 108091033319 polynucleotide Proteins 0.000 claims description 6
- 102000040430 polynucleotide Human genes 0.000 claims description 6
- 239000002157 polynucleotide Substances 0.000 claims description 6
- 210000003705 ribosome Anatomy 0.000 claims description 6
- 230000002194 synthesizing effect Effects 0.000 claims description 5
- 241000020089 Atacta Species 0.000 claims description 4
- 241001200922 Gagata Species 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 2
- 238000013519 translation Methods 0.000 description 28
- 230000000694 effects Effects 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 13
- 239000005090 green fluorescent protein Substances 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 8
- 108060001084 Luciferase Proteins 0.000 description 8
- 239000005089 Luciferase Substances 0.000 description 8
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 7
- 102000016938 Catalase Human genes 0.000 description 6
- 108010053835 Catalase Proteins 0.000 description 6
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 6
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 6
- 108091029865 Exogenous DNA Proteins 0.000 description 5
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 102000007469 Actins Human genes 0.000 description 4
- 108010085238 Actins Proteins 0.000 description 4
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 4
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 4
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 4
- 108090000331 Firefly luciferases Proteins 0.000 description 4
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 4
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 4
- 230000003042 antagnostic effect Effects 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 3
- UBAVPHLFRVPRCI-CRBCFSCISA-N 2-[[(e)-2-carboxyethenyl]amino]-n-methoxy-2-oxoethanimine oxide Chemical compound CO\[N+]([O-])=C\C(=O)N\C=C\C(O)=O UBAVPHLFRVPRCI-CRBCFSCISA-N 0.000 description 3
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 3
- 108010073141 Hepatitis C virus glycoprotein E2 Proteins 0.000 description 3
- 101000744718 Homo sapiens YTH domain-containing family protein 3 Proteins 0.000 description 3
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 102100040018 Interferon alpha-2 Human genes 0.000 description 3
- 108010078049 Interferon alpha-2 Proteins 0.000 description 3
- 102000003777 Interleukin-1 beta Human genes 0.000 description 3
- 108090000193 Interleukin-1 beta Proteins 0.000 description 3
- 241000235649 Kluyveromyces Species 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 102000019200 Poly(A)-Binding Protein I Human genes 0.000 description 3
- 108010012887 Poly(A)-Binding Protein I Proteins 0.000 description 3
- 108010071690 Prealbumin Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- 102000009190 Transthyretin Human genes 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 108020000999 Viral RNA Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 102100039674 YTH domain-containing family protein 3 Human genes 0.000 description 3
- 102000004139 alpha-Amylases Human genes 0.000 description 3
- 108090000637 alpha-Amylases Proteins 0.000 description 3
- 229940024171 alpha-amylase Drugs 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- 108091093088 Amplicon Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 102000043856 Leucine-tRNA ligase Human genes 0.000 description 2
- 108010071170 Leucine-tRNA ligase Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 108020005067 RNA Splice Sites Proteins 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 108091027963 non-coding RNA Proteins 0.000 description 2
- 102000042567 non-coding RNA Human genes 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 108091023037 Aptamer Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000710188 Encephalomyocarditis virus Species 0.000 description 1
- 101900264058 Escherichia coli Beta-galactosidase Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 241000235650 Kluyveromyces marxianus Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000009699 differential effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
- PCT国内申请,权利要求书已公开。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410093532.8A CN117965533A (zh) | 2019-03-20 | 2020-02-27 | 利用环形rna进行蛋白翻译及其应用 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910214234.9A CN111718929B (zh) | 2019-03-20 | 2019-03-20 | 利用环形rna进行蛋白翻译及其应用 |
CN2019102142349 | 2019-03-20 | ||
PCT/CN2020/077026 WO2020186991A1 (zh) | 2019-03-20 | 2020-02-27 | 利用环形rna进行蛋白翻译及其应用 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410093532.8A Division CN117965533A (zh) | 2019-03-20 | 2020-02-27 | 利用环形rna进行蛋白翻译及其应用 |
CN202410975296.2A Division CN118834867A (zh) | 2019-03-20 | 2020-02-27 | 利用环形rna进行蛋白翻译及其应用 |
CN202410975341.4A Division CN118834868A (zh) | 2019-03-20 | 2020-02-27 | 利用环形rna进行蛋白翻译及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113825837A true CN113825837A (zh) | 2021-12-21 |
Family
ID=72519626
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211124976.0A Pending CN115806976A (zh) | 2019-03-20 | 2019-03-20 | 利用环形rna进行蛋白翻译及其应用 |
CN201910214234.9A Active CN111718929B (zh) | 2019-03-20 | 2019-03-20 | 利用环形rna进行蛋白翻译及其应用 |
CN202410093532.8A Pending CN117965533A (zh) | 2019-03-20 | 2020-02-27 | 利用环形rna进行蛋白翻译及其应用 |
CN202080036818.2A Pending CN113825837A (zh) | 2019-03-20 | 2020-02-27 | 利用环形rna进行蛋白翻译及其应用 |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211124976.0A Pending CN115806976A (zh) | 2019-03-20 | 2019-03-20 | 利用环形rna进行蛋白翻译及其应用 |
CN201910214234.9A Active CN111718929B (zh) | 2019-03-20 | 2019-03-20 | 利用环形rna进行蛋白翻译及其应用 |
CN202410093532.8A Pending CN117965533A (zh) | 2019-03-20 | 2020-02-27 | 利用环形rna进行蛋白翻译及其应用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20220177898A1 (zh) |
EP (1) | EP3943601A4 (zh) |
JP (2) | JP7297331B2 (zh) |
CN (4) | CN115806976A (zh) |
WO (1) | WO2020186991A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112608946B (zh) * | 2021-01-17 | 2023-07-28 | 楷拓生物科技(苏州)有限公司 | 一种环状rna载体及其在疫苗中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109423496A (zh) * | 2017-08-31 | 2019-03-05 | 康码(上海)生物科技有限公司 | 一种细胞中内源性表达rna聚合酶的核酸构建物 |
CN109423497A (zh) * | 2017-08-31 | 2019-03-05 | 康码(上海)生物科技有限公司 | 增强蛋白质合成效率的rna元件 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1282697E (pt) * | 2000-03-28 | 2008-02-01 | Univ Queensland | Construção capaz de libertação na forma circular fechada a partir de uma grande sequência nucleotídica permitindo a expressão específica do local e/ou a expressão regulada durante o desenvolvimento de sequências genéticas seleccionadas |
WO2012177639A2 (en) * | 2011-06-22 | 2012-12-27 | Alnylam Pharmaceuticals, Inc. | Bioprocessing and bioproduction using avian cell lines |
CN105985978B (zh) * | 2015-03-06 | 2020-02-14 | 中国科学院上海生命科学研究院 | 一种新型rna环化表达载体的构建及其应用 |
CN111819185A (zh) * | 2017-12-15 | 2020-10-23 | 旗舰创业创新第六有限责任公司 | 包含环状多核糖核苷酸的组合物及其用途 |
CN109971775B (zh) * | 2017-12-27 | 2021-12-28 | 康码(上海)生物科技有限公司 | 一种核酸构建物及其调控蛋白合成的方法 |
-
2019
- 2019-03-20 CN CN202211124976.0A patent/CN115806976A/zh active Pending
- 2019-03-20 CN CN201910214234.9A patent/CN111718929B/zh active Active
-
2020
- 2020-02-27 EP EP20773279.3A patent/EP3943601A4/en active Pending
- 2020-02-27 US US17/440,774 patent/US20220177898A1/en active Pending
- 2020-02-27 WO PCT/CN2020/077026 patent/WO2020186991A1/zh unknown
- 2020-02-27 CN CN202410093532.8A patent/CN117965533A/zh active Pending
- 2020-02-27 CN CN202080036818.2A patent/CN113825837A/zh active Pending
- 2020-02-27 JP JP2021559486A patent/JP7297331B2/ja active Active
-
2023
- 2023-06-07 JP JP2023094068A patent/JP2023116620A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109423496A (zh) * | 2017-08-31 | 2019-03-05 | 康码(上海)生物科技有限公司 | 一种细胞中内源性表达rna聚合酶的核酸构建物 |
CN109423497A (zh) * | 2017-08-31 | 2019-03-05 | 康码(上海)生物科技有限公司 | 增强蛋白质合成效率的rna元件 |
Non-Patent Citations (2)
Title |
---|
XIAOJUAN FAN 等: "Pervasive translation of circular RNAs driven by short IRES-like elements.", 《BIORXIV》 * |
YANG YUN等: "Extensive translation of circular RNAs driven by N-6-methyladenosine.", 《CELL RESEARCH》 * |
Also Published As
Publication number | Publication date |
---|---|
JP7297331B2 (ja) | 2023-06-26 |
CN111718929B (zh) | 2022-10-18 |
JP2023116620A (ja) | 2023-08-22 |
CN115806976A (zh) | 2023-03-17 |
US20220177898A1 (en) | 2022-06-09 |
CN117965533A (zh) | 2024-05-03 |
CN111718929A (zh) | 2020-09-29 |
EP3943601A4 (en) | 2022-12-14 |
EP3943601A1 (en) | 2022-01-26 |
WO2020186991A1 (zh) | 2020-09-24 |
JP2022528252A (ja) | 2022-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Leppek et al. | Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics | |
US11268089B2 (en) | Method for the construction of specific promoters | |
Yamanishi et al. | A genome-wide activity assessment of terminator regions in Saccharomyces cerevisiae provides a ″terminatome ″toolbox | |
Deaner et al. | Modular ligation extension of guide RNA operons (LEGO) for multiplexed dCas9 regulation of metabolic pathways in Saccharomyces cerevisiae | |
Tanaka et al. | Effects of codon optimization on the mRNA levels of heterologous genes in filamentous fungi | |
Specht et al. | Synthetic oligonucleotide libraries reveal novel regulatory elements in Chlamydomonas chloroplast mRNAs | |
WO2008023247A2 (en) | Matrix attachment regions (mars) for increasing transcription and uses thereof | |
Brown et al. | Whole synthetic pathway engineering of recombinant protein production | |
CN103080123A (zh) | 组合物以及用于生产蛋白质的方法 | |
Berg et al. | Modulating mistranslation potential of tRNASer in Saccharomyces cerevisiae | |
CN113227387A (zh) | 基于单细胞转录组开发aav载体和启动子的方法和材料 | |
EP3686282A1 (en) | Promoter | |
Hummel et al. | The trans-regulatory landscape of gene networks in plants | |
JP2023116620A (ja) | 環状rnaを使用したタンパク質翻訳およびその応用 | |
WO2021136347A1 (zh) | 一种哺乳动物表达系统使用的高表达载体 | |
Yu et al. | Transcriptome analyses of insect cells to facilitate baculovirus-insect expression | |
CN118834867A (zh) | 利用环形rna进行蛋白翻译及其应用 | |
Liu et al. | Leaderless bicistronic design for precise and reliable control of gene expression in Corynebacterium glutamicum | |
CN118834868A (zh) | 利用环形rna进行蛋白翻译及其应用 | |
Wang et al. | Parallel gene cloning and protein production in multiple expression systems | |
WO2024147331A1 (ja) | タンパク質発現増強用核酸 | |
WO2023233996A1 (ja) | 改変プロモーター、発現ベクター、微生物、物質の生産方法、改変シアノバクテリア及び改変プロモーターの作製方法 | |
Mavor et al. | Mapping the growth effect of previously hidden ubiquitin alleles using an overexpression based mutational scan | |
CN115851715A (zh) | 一种水牛骨骼肌特异高效启动子及其筛选方法和应用 | |
CN114774421A (zh) | 运动发酵单胞菌内源性启动子突变体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40057766 Country of ref document: HK |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20231127 Address after: 200131, Room 901, 9th Floor, No. 8 Jiafeng Road, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai Applicant after: Shanghai Huanma Biopharmaceutical Co.,Ltd. Address before: No.319, Yueyang Road, Xuhui District, Shanghai 200031 Applicant before: Shanghai Institute of nutrition and health, Chinese Academy of Sciences |